Dmitry Rogachev Federal Research and Clinical Centre of Paediatric Haematology, Oncology and Immunology Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2016
NCT03019809
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Director of Institute of Oncology, Radiology and Nuclear Medicine. Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology | Director of Institute of Oncology, Radiology and Nuclear Medicine. Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology. | Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology | Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology